Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 3:00 AM ET

Date/Time Source News Release
05/27/2025 04:05 PM EDT GlobeNewswire Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
05/08/2025 04:05 PM EDT GlobeNewswire Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates
05/07/2025 08:00 AM EDT GlobeNewswire New Preclinical Data for Assembly Biosciences' Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025
04/09/2025 02:00 AM EDT GlobeNewswire Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
03/20/2025 04:05 PM EDT GlobeNewswire Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
02/26/2025 08:00 AM EST GlobeNewswire Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
02/20/2025 08:00 AM EST GlobeNewswire Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes
12/26/2024 08:00 AM EST GlobeNewswire Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B
12/19/2024 08:00 AM EST GlobeNewswire Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs
11/07/2024 04:05 PM EST GlobeNewswire Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
Page

Additional News

As of June 7, 2025 • 3:00 AM ET

Date/Time Source News Release
06/06/2025 10:00 AM EDT Stock Traders Daily (ASMB) Pivots Trading Plans and Risk Controls
05/16/2025 12:46 PM EDT Stock Traders Daily Trend Tracker for (ASMB)
05/14/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 14th, 2025
05/14/2025 05:30 AM EDT US Earnings Reports Expected earnings - Assembly Biosciences Inc.
05/08/2025 05:40 PM EDT Zacks Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates
05/08/2025 05:30 PM EDT SeekingAlpha Assembly Biosciences GAAP EPS of -$1.17 beats by $0.43, revenue of $9.42M beats by $2.01M
05/07/2025 05:35 PM EDT Zacks Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates
05/05/2025 09:47 AM EDT Zacks Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?
04/29/2025 05:35 PM EDT Zacks BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates
04/08/2025 09:35 AM EDT Zacks Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.